Prediction of Outcome After Mitral Valve Replacement in Patients With Symptomatic Chronic Mitral Regurgitation
The Importance of Left Atrial Size David Reed, MD; Robert D. Abbott, PhD; Mark L. Smucker, MD; and Sanjiv Kaul, MD Background. The ability to predict outcome after mitral valve replacement remains limited in patients with symptomatic chronic mitral regurgitation. The aims of this study were to determine the preoperative predictors of postoperative cardiac-related mortality and to assess the additive prognostic value of tests performed in such patients. Methods and Results. Accordingly, 176 patients (mean age, 57±14 years) who underwent mitral valve replacement were followed up for 3.8+0.5 years. Four categories of variables were analyzed to predict postoperative cardiac-related mortality: clinical, laboratory, two-dimensional echocardiographic (2DE), and cardiac catheterization. There were 39 cardiac-related deaths (29 due to congestive heart failure and 10 sudden). When the four categories were analyzed separately, two clinical, one laboratory, two 2DE, and one catheterization variable best predicted postoperative death. When these six variables were examined simultaneously, only three (one clinical and two 2DE) remained significant predictors of cardiac-related mortality: presence of pulmonary rales, left atrial size, and the ratio of left ventricular wall thickness to left ventricular cavity dimension in end systole. A model based on these three variables may predict cardiac-related death with considerable accuracy. Laboratory data did not add to clinical information for predicting death. 2DE variables provided significant additional information in this regard (p<0.001). Further addition of catheterization variables was not useful. Prognostic value did not change significantly when 50 patients with prior mitral valve surgery or 49 patients undergoing concomitant aortic valve replacement or coronary artery bypass surgery were excluded from analysis.
Conclusions. We conclude that 1) measures of both left ventricular systolic function and left atrial size are equally important in predicting postoperative cardiac-related mortality in patients with symptomatic chronic mitral regurgitation undergoing mitral valve replacement; 2) left atrial size may be important because it reflects the "history" (severity and duration) of mitral regurgitation; 3) 2DE assessment. of left atrial size and left ventricular function provides prognostic information that is significantly greater than that obtained from clinical and laboratory parameters alone; the addition of catheterization variables does not increase the prognostic value of the clinical and 2DE data. (Circulation 1991;84: [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] T he ability to predict outcome after mitral valve replacement (MVR) remains limited in patients with symptomatic chronic mitral regurgitation (MR).1,2 In patients being considered for MVR, attention is usually focused on left ventricular (LV) size and systolic function.1-'8 Simple1-6'8-14 and complex7415-18 measures of LV size and systolic func-outcome after MVR. That these parameters have been only partially successful in predicting outcome is related to the occurrence of myocardial dysfunction resulting from chronic volume overload. Before operation, this dysfunction is masked by favorable loading conditions, particularly the presence of the low impedance in the left atrium (LA). 26, 18 When such patients with apparently "normal" LV function undergo MVR, the loading conditions are unfavorably affected, and significant myocardial dysfunction may become apparent, which may lead to worsening of congestive heart failure and death. [1] [2] [3] [4] Nearly every symptomatic patient with chronic MR undergoes a comprehensive clinical evaluation, laboratory tests including electrocardiography (ECG), two-dimensional echocardiography (2DE), and cardiac catheterization. No study to date has critically examined the entire body of data available to physicians in determining the feasibility of MVR in a particular patient.
The aims of the present study, therefore, were to 1) evaluate all routinely available clinical, laboratory, 2DE, and catheterization data in symptomatic patients with chronic MR to predict outcome after MVR; and 2) assess the additive value of tests done in succession for determining outcome in such patients. We wanted to examine whether the ECG added to the clinical data, 2DE added to the clinical and ECG data, and cardiac catheterization added to the clinical, ECG, and 2DE data for the determination of clinical outcome. This sequence was chosen because it is the order in which data are usually collected.
Methods

Patient Population
One hundred seventy-six consecutive patients with symptomatic chronic MR referred to the University of Virginia Hospital for MVR between January 1, 1979, and March 31, 1987 , form the basis of this study. There were 96 men and 80 women who were 57±+14 years old. Patients with concomitant mitral stenosis were not included in this analysis. Fifty patients with prior mitral valve surgery (14 with commissurotomy, 44 with MVR, and eight with both) were included; also, 10 patients with prior aortic valve replacement and 10 patients with previous coronary artery bypass surgery were included. One hundred thirty-one patients underwent isolated MVR; 18 also had concomitant aortic valve replacement, 34 had concomitant coronary artery bypass surgery, and 11 had both. In addition, 10 patients underwent tricuspid valve annuloplasty, and three underwent tricuspid valve replacement. MR was believed to be the predominant lesion in all of these patients.
Clinical Variables
The 30 clinical variables analyzed are listed in the Appendix. These include age, gender, New York Heart Association functional class, associated symptoms, associated systemic or noncardiac disorders, 
Laboratory Findings
Nine ECG and clinical chemistry variables (see Appendix) were analyzed. The ECG findings and blood urea nitrogen and serum creatinine levels were available in all but 11 patients. In 29 patients, the other chemistry data were not available.
Echocardiography Data
Routinely performed 2DE studies were analyzed off-line with an image processing computer (Mipron System, Kontron Electronics, Eching, FRG.). 19 The computer was calibrated for all the commercial 2DE systems used for this study. Phantoms of known dimensions were imaged using each system at each field depth, and the x and y calibration factors were programmed into the system. The 15 2DE measurements analyzed are listed in the Appendix. The left atrium was measured both in the parasternal long-axis and apical four-chamber views (Figure 1 ).20 A LA size index was derived by multiplying the maximal transverse and longitudinal dimensions obtained from the apical four-chamber view. The LV end-diastolic and end-systolic dimensions were measured in the parasternal long-axis view,20 and fractional shortening and dimension indexes were derived.'4 LV wall thickness represents the mean of interventricular septal and posterior wall thicknesses obtained from the parasternal long-axis view. The ratio of wall thickness to LV cavity dimension at end systole was derived. Also, the product of this ratio and systolic blood pressure was assessed. These two indexes provide estimates of systolic wall stress. 21, 22 The right ventricular cavity dimension was measured in the apical four-chamber view.20 Only 148 patients had technically adequate 2DE studies suitable for analysis.
Cardiac Catheterization Data
The 15 catheterization variables analyzed are listed in the Appendix. These include right and left heart pressures, end-diastolic and end-systolic LV volumes (absolute and indexed to body surface area),11,13 LV ejection fraction, and presence of concomitant valvular or coronary artery disease. These data were available in 163 patients. Special measurements performed to determine LV contractility such as peak systolic LV stress-volume relations were not performed from these routinely derived data. The regurgitant volumes and fractions and the product of LV ejection fraction and regurgitant fraction (which is equal to regurgitant volume divided by end-diastolic volume) were available only in 130 patients.
Follow-up
Follow-up was obtained in all patients by contacting the patient or the patient's family or the patient's physician. The cause of death was confirmed by the referring physician and by hospital records. Only cardiac-related death was considered an event. Deaths related to prosthetic dysfunction or endocarditis were not considered to be cardiac related. All cardiac deaths analyzed in this study, therefore, were related to poor LV function and ventricular arrhythmias. The patients were followed up for 2 to 7.5 years (mean, 3.8+0.5 years).
Data Analysis
To determine the variables that predicted cardiacrelated death, Cox regression analysis was performed separately on clinical, laboratory, 2DE, and catheterization data.23 Noncardiac-related deaths were censored at the time of death. The univariate relative risk was then derived for each significant risk factor. It was based on comparison between patients differing in each particular characteristic by 1 standard deviation of the risk factor. For dichotomous risk factors, the relative risk was based on the presence or absence of the risk factor. The significant predictors were then forced into the Cox model to determine the most important overall predictors of death and to derive relative risk based on multivariate analysis. This analysis was performed by 1) including all patients, 2) excluding patients who underwent concomitant aortic valve replacement or coronary artery bypass surgery, and 3) excluding patients who had undergone previous mitral valve surgery.
A modification of the Cox regression analysis allowed us to develop a model to compute the probability of death for each patient.24,25 To evaluate model fit, observed rates of cardiac-related death were compared with the predicted rates using the model. The predicted rates were calculated by ranking the individual probabilities, which were then grouped into tertiles; patients who fell into the lowest tertile were predicted to have the lowest death rates predicted to have the highest death rates. Within each tertile, the predicted death rate was determined by averaging the individual probabilities that were then compared with the actual death rates.
Event-free survival was plotted with Kaplan-Meier curves for three groups of LA size.26 These groups consisted of patients with mean normal LA size or less (.16 cm2), from the mean to mean+1 SD of normal LA size (>16 cm2 to 24 cm2), more than mean+1 SD of normal LA size (>24 cm2).20 Survival curves adjusted for selected variables were also plotted.27 '28 To determine the additive value of each category of tests to predict death, the significant predictors from each category (clinical, laboratory, 2DE, and catheterization) were forced into a Cox model in a stepwise manner. The significant laboratory predictors were first included with the clinical predictors. The 2DE predictors were then added to the clinical and laboratory predictors, and last, all the significant predictors (including catheterization) were forced into the model. The additive value of each group of data was assessed by use of the likelihood ratio statistic.30
Results
There were 61 deaths of which 39 were classified as cardiac related (nonprosthetic related). Twenty-nine of these were related directly to either a postoperative low-output state or to chronic congestive heart failure; the other 10 were sudden. There were no differences between patients dying of heart failure and those dying suddenly. Nine of the 39 cardiacrelated deaths occurred within 30 days of the operation. There were no significant differences between patients dying within the first 30 days and those dying later. Of the 22 noncardiac-related deaths, four were due to multisystem failure; nine were secondary to sepsis or endocarditis; one was due to excessive bleeding; three were due to pulmonary complications; one was due to cerebral embolism; and four were related to prosthetic valve dysfunction.
Univariate Analysis
The results of the univariate Cox analysis in patients who died from cardiac causes and those who did not are depicted in Table 1 . There was no difference in the two groups in terms of age, gender, and history of coronary artery disease, hypertension, congestive heart failure, prior mitral valve or coronary artery bypass surgery, or the presence of an increased pulmonary component of the second heart sound. Patients who died had a higher functional class and a greater prevalence of diabetes, smoking, and pulmonary rales on preoperative physical examination. Although the incidence of right-axis deviation on the ECG was small, it was significantly higher in those who died. The preoperative serum creatinine and blood urea nitrogen levels were higher in patients who died.
2DE examination showed a significantly larger LA size in patients who suffered cardiac-related death and those who fell into the highest tertile were ( Table 1 ). The LA size was larger in both the parasternal long-axis and apical four-chamber views. Preoperative LV systolic function was worse in the patients who died; their end-systolic cavity dimension was greater and their end-systolic wall thickness was smaller than those who survived. The ratio of LV free wall thickness divided by LV cavity dimension in end systole was smaller in patients who died from cardiac causes. On cardiac catheterization, the cardiac index and pressures in the right-sided chambers were similar in those who died and those who survived. The patients who died had a higher pulmonary capillary wedge pressure and a lower LV ejection fraction. Table 2 lists the variables selected as significant predictors of death from each category (clinical, laboratory, 2DE, and cardiac catheterization). Of the variables analyzed (Appendix), six were selected to be of prognostic value. The univariate relative risk (with 95% confidence intervals) for death for each variable is listed in Table 2 . Smoking and pulmonary rales increased this risk by more than two times. An increase in serum creatinine by 0.7 mg/mI increased the likelihood of death by one third. The LA index derived from the apical four-chamber view on 2DE was a strong risk factor. The chances of dying increased by twofold for every 7.0 cm2 increase in this parameter. The ratio of LV free wall thickness divided by LV cavity dimension in end systole correlated inversely with the risk of death. For every increase in this ratio by 0.20, the chance of dying was halved. LV ejection fraction also correlated inversely with the risk of postoperative death. For an increase in LV ejection fraction by 0.15, the likelihood of death decreased by one third.
Multivariate Analysis
When the six variables listed in Table 2 were combined into a Cox model in the 139 patients in whom all these variables were available, only three variables (one clinical and two 2DE) were found to be significant predictors of death. These included the presence of pulmonary rales, LA index, and the ratio of LV free wall thickness divided by the LV cavity dimension in end systole. The risk of death doubled in the presence of pulmonary rales. It increased by more than two times with every increase in LA size index by 7.0 cm2, and for every decrease in the ratio of LV wall thickness divided by LV cavity size in end systole, by 0.20. The relative risk of the other three variables decreased to nonsignificant levels ( Table 2 ). Although many of the clinical, laboratory, and catheterization variables were significant predictors of cardiac-related death on a univariate basis, none added to the power of pulmonary rales and to the two 2DE variables described above in predicting death. Based on these results, the following model was developed in the 148 patients in whom all the significant variables were available: where a is 1 for pulmonary rales present and 0 for pulmonary rales absent, b is LA index, and c is the ratio of LV free wall thickness to LV cavity dimension in end systole. When death was predicted based on this model, the predicted rate was almost identical in each third of the range (tertile) of the actual death rate (Figure 2 ).
Survival Analysis
The Kaplan-Meier survival curves based upon the LA index derived from the 2DE four-chamber view in the 148 patients in whom these data were available are illustrated in Figure 3 . Of these patients, 38 had cardiac-related deaths. The dotted line represents Figure 4 illustrates survival curves based on LA index adjusted for the other two significant risk factors on multivariate analysis: presence of pulmonary rales and ratio of LV free wall to LV cavity dimension in end systole. The differences between the survival curves are less after adjustment. Of the 20 patients with normal LA size, six had pulmonary rales, and nine had reduced systolic LV function (LV ejection fraction, <0.55); three had both. Of the 63 patients with a severely enlarged LA (index, >24), 35 had no rales, and 47 had "normal" LV systolic function (LV ejection fraction, >0.55), and 55 had both. Despite the strong influence of pulmonary rales and LV systolic function, however, the differences between adjusted survival curves based on LA size remained highly significant.
Relative Value of Different Tests
When the significant clinical, laboratory, 2DE, and cardiac catheterization variables were forced separately (clinical alone, laboratory alone, etc.) into a Cox model, the 2DE data provided information with the greatest prognostic value. The the four categories are depicted in Figure 5 . In this regard, although LV end-systolic volume index was nearly identical in its prognostic power to LV ejection fraction, it was superseded by the latter when all catheterization variables were considered together. Similarly, the product of regurgitant fraction and LV ejection fraction that equals the ratio of regurgitant volume to LV end-diastolic volume was highly predictive of postoperative outcome in the 128 patients in whom this parameter was available. When catheterization variables, however, were forced into a model with all patients, it was also superseded by LV ejection fraction.
Incremental Value of Different Tests
When the significant variables from each category were forced into a Cox model in a hierarchical manner, the addition of the laboratory variables did not increase the prognostic yield of the known clinical variables (increase in the likelihood ratio statistic by 3.6, p=NS, DF=1) as depicted in Figure 6 . In contrast, 2DE predictors considerably enhanced the overall power of the model to predict death (increase in the likelihood ratio statistic by 22.07, p<0.001, DF=2). The further addition of the significant catheterization variables did not enhance the power of the model to predict death (increase in the likelihood ratio statistic by O. 1 1, p = NS, DF = 1).
Excluding Patients Undergoing Concomitant Coronary Artery Bypass Surgery or Aortic Valve Replacement
When the 49 patients undergoing concomitant aortic valve replacement (18) (34) or both (11) were excluded from analysis, four risk factors were identified for the 23 cardiac-related deaths. Their univariate relative risk with the 95% confidence intervals are depicted in Table 3 . Similar to the findings in the entire patient cohort, pulmonary rales remained a significant clinical predictor of cardiac-related death, whereas unlike the findings in the entire patient cohort, smoking was not found to be a significant predictor of cardiacrelated mortality. The 2DE predictors of cardiacrelated mortality remained unchanged compared with the entire population. Unlike the entire population, however, no laboratory variables were identified as significant predictors of cardiac-related mortality, and pulmonary capillary wedge pressure, rather than LV ejection fraction, was identified as the most significant predictor of death at cardiac catheterization. Apart from this last variable, all others remained significant predictors of cardiac-related mortality on multivariate analysis (Table 3) .
Excluding Patients Who Had Undergone Prior Mitral Valve Surgery
When the 50 patients with prior mitral valve surgery (14 with commissurotomy, 44 with MVR, and eight with both) were excluded from analysis, four risk factors were identified for the 25 cardiac-related deaths. Table 4 lists their univariate relative risk with the 95% confidence intervals. Instead of pulmonary rales and smoking, history of diabetes was the significant clinical predictor of cardiac-related mortality. The 2DE predictors remained unchanged compared with the entire cohort. Unlike the entire cohort, however, no laboratory predictors of cardiac-related mortality were identified. Similar to the entire population, LV ejection fraction was the significant predictor of mortality at cardiac catheterization. Except for this last variable, all others remained significant predictors of cardiac-related death on multivariate analysis (Table 4 ).
Discussion
The goals of this study were 1) to determine which of the variables routinely obtained in patients with symptomatic chronic MR are predictive of postoperative cardiac-related mortality after MVR, and 2) to assess the additive prognostic value of tests performed in succession for predicting cardiac-related death in these patients. Our results indicate that the LA size is an important predictor of postoperative death and complements LV systolic function in this regard. The prognostic information available in these two variables and pulmonary rales supersedes that inherent in all other clinical, laboratory, 2DE, and catheterization data. 2DE data provide valuable additional prognostic information compared with the clinical data alone. Once the clinical and 2DE data are available, further addition of catheterization data does not increase prognostic information. Value of Left Atrial Size Surgeons have known for some time that a severely enlarged left atrium in a patient with chronic MR portends a poor prognosis after MVR. 31 No systematically performed study, however, has addressed this issue. In the present study, we found that LA size is one of the most important determinants of outcome after MVR. It complements LV systolic function in predicting postoperative outcome. In our patients who had "normal" LV systolic function (LV ejection fraction from 0.50 to 0.75), LA size was equally as important as LV systolic function (measured as the ratio of LV free wall thickness to LV cavity dimension in end systole). When LV systolic function was obviously reduced as in the 29 patients with LV ejection fraction of less than 0.50, LV systolic function (measured as the above-mentioned ratio) was the only significant predictor of the nine cardiacrelated deaths that occurred in this subgroup. LA size and pulmonary rales did not predict these deaths. In comparison, when LV systolic function was "supernormal" as in the 37 patients with LV ejection fraction of more than 0.75, LA size was the only predictor of the seven cardiac-related deaths that occurred among these patients. LV systolic function and pulmonary rales did not predict these deaths.
There are several reasons why LA size may offer important prognostic information. First, LA size re-flects the "history" of the MR: The more severe the MR, the larger the LA; the more chronic the MR, the larger the LA.32 A logarithmic relation between LA size and duration of MR has been previously demonstrated. 33 Second, unlike LV systolic function, in patients with chronic MR, LA size may not be greatly affected by minute-to-minute changes in the loading conditions of the heart. We recently demonstrated that when afterload and preload are acutely altered in patients with chronic MR, while LV dimensions and wall stress change significantly, LA size does not. 34 Third, the degree of MR may itself, to some extent, be influenced by the compliance of the LA. Last, LA size is also influenced by impaired LV diastolic function, often present in patients with chronic MR. 35 The more "stiff' the LV, the larger the LA. LA size may, therefore, reflect the influence of several factors that by themselves are difficult to measure on a routine basis.
Clinicians have always known that the left atrium is enlarged in patients with chronic MR.36 Cineangiography, the most commonly used method to assess the severity of MR, however, has not generally been used to measure LA size. 2DE, on the other hand, is used routinely to assess LA size.37-39 Whereas, the LA size is commonly measured from the parasternal long-axis view (LA1 in Figure 1 ), LA enlargement is sometimes more obvious from the apical four-chamber view (LA2 and LA3 in Figure 1 ). Estimation of LA size is routinely performed in the parasternal long-axis view because on M-mode echocardiography data are collected only from the parasternal location.37 In many echocardiographic laboratories, measurements of cardiac chambers are still routinely obtained on M-mode rather than 2DE. In our study, although LA size measured from the parasternal long-axis view was larger in patients who died, it did not provide the same prognostic information as LA size measured from the apical four-chamber view. Because we did not measure LA area in the four-chamber view, we derived an LA size index by multiplying the major and minor LA dimensions in that view (LA2 and LA3 in Figure 1 ). Measurement of LA area would have provided similar information. On-line measurement of areas is now available on most commercial 2DE systems.
Role of Left Ventricular Systolic Function
Because the most frequent cause of morbidity and death after MVR in patients with chronic MR is postoperative LV dysfunction, attempts to determine postoperative outcome have been largely focused on preoperative LV function.1-18 Routine measurements of LV function performed preoperatively have been found to be partially successful in determining postoperative outcome in patients undergoing MVR. '-14 Our study in no way detracts from these previous observations. In our patients, LV systolic function assessed on 2DE (ratio of LV free wall thickness to LV dimension in end systole) was a powerful predictor of postoperative outcome. In combination with LA size and pulmonary rales, this variable provided an accurate prediction of postoperative cardiac-related mortality in this population.
Other parameters of LV systolic function such as LV ejection fraction, LV end-systolic volume index, and LV end-systolic dimension index were also found to be univariate predictors of cardiac-related mortality. The product of systolic blood pressure and the ratio of LV wall thickness to LV cavity dimension in end systole, which is a measure of systolic wall stress, was also identified as a strong univariate predictor of cardiac-related mortality. The reason it was not found to be as powerful a predictor as the ratio of LV wall thickness to LV cavity dimension alone may be related to the fact that the blood pressure and 2DE data were collected at different times. Some of these parameters may have been found to be superior to the ratio of LV wall thickness to LV cavity dimension in end systole had it been possible to calculate these in all patients.
Patients with "normal" LV function can also suffer adverse outcome. One fourth of the deaths in our study occurred in patients with preoperative LV ejection fractions of more than 0.65. This finding should not be surprising. The LA serves as a lowimpedance chamber to which a significant portion of the LV stroke volume gets diverted in the presence of MR. This altered afterload makes the LV appear to be functioning normally even though it may be irreversibly damaged.12 After MVR when the LA is no longer available for systolic LV decompression, postoperative LV systolic function may become drastically reduced. Because of the effect of the loading conditions on routine measurements of LV systolic function, more sophisticated measurements of LV function have been suggested. [15] [16] [17] [18] These are purported to be relatively unaffected by changes in preload and afterload. These measurements have not, however, achieved widespread use, and prognostic judgments in the clinical setting are mostly based upon LV volumes and ejection fraction. Furthermore, not all studies indicate that these special measurements offer significant advantage over rou-preoperative determinants of outcome in patients undergoing MVR.7 '15 Relative and Incremental Value of Various Tests Because a patient usually undergoes a clinical examination followed by ECG, laboratory, and 2DE evaluation before undergoing cardiac catheterization, we examined the additional role of these separate evaluations performed in a hierarchical fashion on postoperative outcome. 40 We found that a complete clinical evaluation provides important prognostic information and that addition of laboratory and ECG parameters is not very useful. In contrast, addition of 2DE variables provides significant additional information in this regard ( Figure 6 ). After a complete clinical and 2DE evaluation, routine measurements performed at cardiac catheterization do not add any significant prognostic information in terms of postoperative outcome.
Cardiac catheterization obviously provides important information regarding the operation to be performed, such as the need for concomitant bypass graft surgery and so on. Our data merely suggest that in the situation that 2DE assessment of LV function and LA size indicate high surgical risk for MVR, and other clinical and laboratory evidence supports this conclusion, the patients can be spared the additional inconvenience, risk, and cost of cardiac catheterization. Previous studies also indicated that 2DE determination of LV chamber size and wall stress may be valuable for assessing outcome after MVR.1'26 '3,14 Cardiac catheterization may, therefore, not be needed to make prognostic judgments in patients with chronic, symptomatic MR.
Influence of Other Factors
Not surprisingly, the history of smoking adversely affected postoperative outcome in our patients and may be related to the effect of smoking on pulmonary function. Renal dysfunction was also found to be an important determinant of postoperative cardiac-related mortality in our patients. The importance of renal function in this situation may be related to the effect of low forward cardiac output in chronic MR on intrarenal hemodynamics. The history of diabetes was a significant predictor of cardiac-related mortality in our patients who did not have previous mitral valve operations. It is likely that the presence of diabetes affected cardiac-related mortality indirectly by inducing significant end-organ damage. Surprisingly, the presence of concomitant coronary artery disease did not seem to be a major risk factor for postoperative cardiac-related mortality in our patient population, nor did the need for concomitant coronary artery bypass surgery. It is likely that better myocardial preservation during open-heart surgery played a major role in precluding coronary artery disease from becoming a major risk factor. In this study, the right ventricular pressures and dimensions were not as important as LA size and pulmonary capillary wedge pressure. The reasons for tinely obtained cineangiographic measurements as the relative lack of importance of right ventricular size and pressures may be related in part to the compliance of the LA and the pulmonary circulation and also to other factors, such as pulmonary disease, which may affect these measurements independent of LA pressure. Previous investigators found right ventricular ejection fraction response to exercise to be a useful predictor of postoperative outcome in patients with chronic MR.9 The response of LV function to exercise has also been demonstrated to be useful in this regard.12 Our study did not evaluate any exercise variables.
Limitations of the Study
There are some limitations to this study. First, the patients analyzed in this study were not limited to isolated MR, although patients with mitral stenosis were excluded. Given the sample size and the fact that MR is often not an isolated clinical condition, these inclusion criteria seem acceptable and probably reflect the kinds of patients encountered in clinical practice. Furthermore, the effect of other concomitant pathologies, such as the presence of significant coronary artery disease, was evaluated by examining patients who did not undergo concomitant coronary artery bypass surgery at the time of MVR. Similarly, the effects of previous mitral valve surgery were evaluated by performing the analysis after excluding such patients. In either case, the results were not affected in a major way.
Second, more complex measures of LV function, such as the LV end-systolic stress-volume relation, were not assessed. The goal of the study was to determine which of the routinely performed measurements is of value in predicting outcome. Special measurements, such as the LV end-systolic pressurevolume relation, are not routinely performed in most catheterization laboratories. Third, postoperative LV function was not assessed as an end point. This parameter may have identified additional risk factors for MVR. We, however, believe that cardiac-related death selected as the "hard" event for this study is a more definitive end point than measurements of LV function.
Fourth, intraoperative variables such as aortic cross-clamp time and the duration of operation were not evaluated because the aim of the study was to examine the preoperative predictors of postoperative outcome. Operative variables are well known to predict outcome, and this information cannot be ignored during clinical decision making.41,42 Furthermore, the manner in which the submitral apparatus is handled intraoperatively may affect the post-operative outcome.43 Because the chordae were transsected in most of our patients at the time these patients were operated on, it is difficult to assess the effect of this maneuver on postoperative outcome in our study. Last, LV systolic function seems less adversely affected in patients undergoing mitral valve repair compared with MVR.4445 A separate study would be required to determine predictors of post-operative outcome in patients undergoing mitral valve repair, which is becoming a more commonly performed surgical procedure in selected patients with chronic MR.
Conclusions
In this study of a large number of patients with chronic symptomatic MR followed up over a long period, we demonstrated that 1) the LA size is an important determinant of postoperative cardiacrelated mortality; 2) LA size and LV systolic function assessed on 2DE provide prognostic information that significantly enhances that available from other clinical, ECG, laboratory, and 2DE variables; and 3) once clinical and 2DE data are available, cardiac catheterization does not provide any additional prognostic information. We believe that the prognostic relevance of LA size may be related to its reflection of the "history" of MR. The relative lack of influence of loading conditions of the heart on LA size in chronic MR may also be a factor. Based on these results, we conclude that LA size should be routinely assessed in symptomatic patients with chronic MR being considered for MVR. 
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